<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906139</url>
  </required_header>
  <id_info>
    <org_study_id>LCorreia</org_study_id>
    <nct_id>NCT00906139</nct_id>
  </id_info>
  <brief_title>Propofol and Fentanyl Versus Midazolam and Fentanyl for Endoscopy Sedation in Cirrhotic Patients</brief_title>
  <official_title>Propofol and Fentanyl Versus Midazolam and Fentanyl for Sedation During Diagnostic or Therapeutic Gastrointestinal Endoscopy in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare propofol associated with fentanyl versus midazolam
      plus fentanyl for sedation during diagnosis or therapeutic upper gastrointestinal endoscopy
      (UGE) in cirrhotic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      UGE is often performed in cirrhotic patients for the diagnosis and treatment of portal
      hypertension complications. Current data suggests that propofol sedation may have advantages
      over benzodiazepines. However, there are few reports comparing propofol versus midazolam in
      patients with liver cirrhosis. The study's objective is to compare propofol associated with
      fentanyl versus midazolam plus fentanyl for sedation during diagnosis or therapeutic UGE in
      cirrhotic patients. A prospective randomized study will include cirrhotic patients (Child A,
      B or C and ASA 2 or 3), referred for diagnostic or therapeutic UGE, randomized for group I:
      propofol (0,5 mg/kg up to 400 mg) and fentanyl (0,05 mg); or group II: midazolam (0,1 mg/kg)
      and fentanyl. Sedation was performed by an exclusively dedicated gastroenterologist. Efficacy
      (completion of procedures), complications (hypoxemia, hypotension, arrhythmias) and recovery
      time (elapsed from the end of the procedure and discharge) will be studied.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">November 2009</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare propofol and fentanyl versus midazolam and fentanyl regarding safety and efficiency</measure>
    <time_frame>Three months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To receive propofol (0.5 mg/kg up to 400 mg) and fentanyl (0.05 mg);</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To receive midazolam (0.1 mg/kg) and fentanyl (0.05 mg).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol dose: 0.5 mg/kg up to 400 mg</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam dose: 0.1 mg/kg</description>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl dose: 0.05 mg</description>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver cirrhosis, any etiology

          -  ASA II or III

          -  Child A, B or C

          -  Age between 18 years and 75 years

          -  Patients that agree in participate of study and signed the contentment term

        Exclusion Criteria:

          -  Schistosomiasis

          -  Recuse

          -  Hepatocellular carcinoma

          -  Contraindications to drugs

          -  ASA IV or V

          -  Hepatic encephalopathy, neurologic diseases

          -  Opioids, narcotics, MAO inhibitors or benzodiazepines use

          -  Alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04024-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <last_update_submitted>May 22, 2009</last_update_submitted>
  <last_update_submitted_qc>May 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Lucianna Pereira da Motta Pires Correia</name_title>
    <organization>Federal University of São Paulo</organization>
  </responsible_party>
  <keyword>Propofol</keyword>
  <keyword>Midazolam</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>Gastrointestinal endoscopy</keyword>
  <keyword>Complications</keyword>
  <keyword>Sedation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 6, 2012</submitted>
    <returned>December 4, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

